198 related articles for article (PubMed ID: 34447973)
1. Pharmacological suppression of the WNT signaling pathway attenuates age-dependent expression of the phenotype in a mouse model of arrhythmogenic cardiomyopathy.
Cheedipudi SM; Fan S; Rouhi L; Marian AJ
J Cardiovasc Aging; 2021; 1(3):. PubMed ID: 34447973
[TBL] [Abstract][Full Text] [Related]
2. Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.
Cheedipudi SM; Hu J; Fan S; Yuan P; Karmouch J; Czernuszewicz G; Robertson MJ; Coarfa C; Hong K; Yao Y; Campbell H; Wehrens X; Gurha P; Marian AJ
Cardiovasc Res; 2020 May; 116(6):1199-1213. PubMed ID: 31350552
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell RNA Sequencing Uncovers Paracrine Functions of the Epicardial-Derived Cells in Arrhythmogenic Cardiomyopathy.
Yuan P; Cheedipudi SM; Rouhi L; Fan S; Simon L; Zhao Z; Hong K; Gurha P; Marian AJ
Circulation; 2021 Jun; 143(22):2169-2187. PubMed ID: 33726497
[TBL] [Abstract][Full Text] [Related]
4. PANoptosis is a prominent feature of desmoplakin cardiomyopathy.
Olcum M; Rouhi L; Fan S; Gonzales MM; Jeong HH; Zhao Z; Gurha P; Marian AJ
J Cardiovasc Aging; 2023 Feb; 3(1):. PubMed ID: 36818425
[TBL] [Abstract][Full Text] [Related]
5. Genetic inactivation of β-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.
Olcum M; Fan S; Rouhi L; Cheedipudi S; Cathcart B; Jeong HH; Zhao Z; Gurha P; Marian AJ
Cardiovasc Res; 2023 Dec; 119(17):2712-2728. PubMed ID: 37625794
[TBL] [Abstract][Full Text] [Related]
6. Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.
Rouhi L; Cheedipudi SM; Chen SN; Fan S; Lombardi R; Chen X; Coarfa C; Robertson MJ; Gurha P; Marian AJ
Cardiovasc Res; 2021 Sep; 117(11):2377-2394. PubMed ID: 33070193
[TBL] [Abstract][Full Text] [Related]
7. The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
Rouhi L; Fan S; Cheedipudi SM; Braza-Boïls A; Molina MS; Yao Y; Robertson MJ; Coarfa C; Gimeno JR; Molina P; Gurha P; Zorio E; Marian AJ
Cardiovasc Res; 2022 May; 118(6):1466-1478. PubMed ID: 34132777
[TBL] [Abstract][Full Text] [Related]
8. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.
Chen SN; Gurha P; Lombardi R; Ruggiero A; Willerson JT; Marian AJ
Circ Res; 2014 Jan; 114(3):454-68. PubMed ID: 24276085
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene.
Lombardi R; Chen SN; Ruggiero A; Gurha P; Czernuszewicz GZ; Willerson JT; Marian AJ
Circ Res; 2016 Jun; 119(1):41-54. PubMed ID: 27121621
[TBL] [Abstract][Full Text] [Related]
10. Humanized
Stevens TL; Manring HR; Wallace MJ; Argall A; Dew T; Papaioannou P; Antwi-Boasiako S; Xu X; Campbell SG; Akar FG; Borzok MA; Hund TJ; Mohler PJ; Koenig SN; El Refaey M
Cells; 2022 Sep; 11(19):. PubMed ID: 36231013
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the
Rouhi L; Auguste G; Zhou Q; Lombardi R; Olcum M; Pourebrahim K; Cheedipudi SM; Asghar S; Hong K; Robertson MJ; Coarfa C; Gurha P; Marian AJ
J Cardiovasc Aging; 2022 Jul; 2(3):. PubMed ID: 35891706
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
Chelko SP; Asimaki A; Lowenthal J; Bueno-Beti C; Bedja D; Scalco A; Amat-Alarcon N; Andersen P; Judge DP; Tung L; Saffitz JE
Circulation; 2019 Oct; 140(18):1491-1505. PubMed ID: 31533459
[TBL] [Abstract][Full Text] [Related]
13. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
Garcia-Gras E; Lombardi R; Giocondo MJ; Willerson JT; Schneider MD; Khoury DS; Marian AJ
J Clin Invest; 2006 Jul; 116(7):2012-21. PubMed ID: 16823493
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Angiotensin Receptor Blockers in a Pre-Clinical Model of Arrhythmogenic Cardiomyopathy.
Landim-Vieira M; Kahmini AR; Engel M; Cannon EN; Amat-Alarcon N; Judge DP; Pinto JR; Chelko SP
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430389
[TBL] [Abstract][Full Text] [Related]
15. Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy.
Roberts JD; Murphy NP; Hamilton RM; Lubbers ER; James CA; Kline CF; Gollob MH; Krahn AD; Sturm AC; Musa H; El-Refaey M; Koenig S; Aneq MÅ; Hoorntje ET; Graw SL; Davies RW; Rafiq MA; Koopmann TT; Aafaqi S; Fatah M; Chiasson DA; Taylor MR; Simmons SL; Han M; van Opbergen CJ; Wold LE; Sinagra G; Mittal K; Tichnell C; Murray B; Codima A; Nazer B; Nguyen DT; Marcus FI; Sobriera N; Lodder EM; van den Berg MP; Spears DA; Robinson JF; Ursell PC; Green AK; Skanes AC; Tang AS; Gardner MJ; Hegele RA; van Veen TA; Wilde AA; Healey JS; Janssen PM; Mestroni L; van Tintelen JP; Calkins H; Judge DP; Hund TJ; Scheinman MM; Mohler PJ
J Clin Invest; 2019 Jul; 129(8):3171-3184. PubMed ID: 31264976
[TBL] [Abstract][Full Text] [Related]
16. A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signalling and miRNA dysregulation.
Calore M; Lorenzon A; Vitiello L; Poloni G; Khan MAF; Beffagna G; Dazzo E; Sacchetto C; Polishchuk R; Sabatelli P; Doliana R; Carnevale D; Lembo G; Bonaldo P; De Windt L; Braghetta P; Rampazzo A
Cardiovasc Res; 2019 Mar; 115(4):739-751. PubMed ID: 30304392
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue.
Maione AS; Pilato CA; Casella M; Gasperetti A; Stadiotti I; Pompilio G; Sommariva E
Front Physiol; 2020; 11():279. PubMed ID: 32317983
[TBL] [Abstract][Full Text] [Related]
18. Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.
Sommariva E; Brambilla S; Carbucicchio C; Gambini E; Meraviglia V; Dello Russo A; Farina FM; Casella M; Catto V; Pontone G; Chiesa M; Stadiotti I; Cogliati E; Paolin A; Ouali Alami N; Preziuso C; d'Amati G; Colombo GI; Rossini A; Capogrossi MC; Tondo C; Pompilio G
Eur Heart J; 2016 Jun; 37(23):1835-46. PubMed ID: 26590176
[TBL] [Abstract][Full Text] [Related]
19. Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.
Lombardi R; Dong J; Rodriguez G; Bell A; Leung TK; Schwartz RJ; Willerson JT; Brugada R; Marian AJ
Circ Res; 2009 May; 104(9):1076-84. PubMed ID: 19359597
[TBL] [Abstract][Full Text] [Related]
20. The homozygous variant c.245G > A/p.G82D in PNPLA2 is associated with arrhythmogenic cardiomyopathy phenotypic manifestations.
Rao M; Guo G; Li M; Chen S; Chen K; Chen X; Song J; Hu S
Clin Genet; 2019 Dec; 96(6):532-540. PubMed ID: 31525260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
